Terry B A
Nurs Clin North Am. 1985 Mar;20(1):207-17.
Two areas of study have made the understanding of infections in Hodgkin's disease and non-Hodgkin's lymphoma both clearer and more complicated. First, the overly simple concepts that certain underlying diseases predispose patients to specific infections can no longer be uniformly applied. Second, while Hodgkin's patients were once thought to have cell-mediated immune defects, we now know that mixed T- and B-cell abnormalities as well as alterations in complement and phagocytic processes are seen. Therefore, we can expect to find infecting organisms against which several immune functions appear to be important. The more common organisms found in these patients include the encapsulated bacteria and fungi, intracellular microbes such as the mycobacteria and certain viruses, and, finally, some protozoa. Many are prevalent in the environment and some are considered to be normal human microbial flora. These opportunistic pathogens will continue to cause serious, often fatal infections in this group of compromised patients until more is known about the causes of lymphoproliferative disease and significant advances in immunotherapy are made.
有两个研究领域使得人们对霍奇金病和非霍奇金淋巴瘤感染的理解变得既更加清晰又更加复杂。首先,某些基础疾病使患者易患特定感染这种过于简单的概念已不再能统一适用。其次,虽然霍奇金病患者曾被认为存在细胞介导的免疫缺陷,但我们现在知道会出现T细胞和B细胞混合异常以及补体和吞噬过程的改变。因此,我们可以预期会发现针对其多种免疫功能似乎很重要的感染病原体。在这些患者中发现的较常见病原体包括包膜细菌和真菌、细胞内微生物如分枝杆菌和某些病毒,以及最后一些原生动物。许多病原体在环境中普遍存在,有些被认为是正常的人类微生物群。在对淋巴增殖性疾病的病因有更多了解并且免疫治疗取得重大进展之前,这些机会性病原体将继续在这组免疫功能受损的患者中引起严重的、往往是致命的感染。